Marc Hennequart

Marc Hennequart is a researcher affiliated with the Namur Research Institute for Life Sciences URPHYM. His work spans cancer metabolism, immune modulation, and molecular mechanisms in tumor biology. He has active projects in pancreatic cancer therapy and detection (2025-2028).

Research Interests: Metabolism-driven oncology, serine and folate pathways, T cell immunology, and amino acid regulation in cancer progression.

Scientific Trends: His recent publications highlight intersections between cancer cell metabolism (proline, serine, folate), redox signaling (ROS), and immune system interactions (T cell responses to dietary compounds like sucralose). Sub_fields include enzyme regulation (ALDH1L2), metastasis mechanisms, and dietary modulation of tumor biology.

Scientific Awards:

• Doctor of Pharmacy, Université Catholique de Louvain (2017)

Collaborations: Works with institutions like University of Glasgow, Université Catholique de Louvain, and cross-disciplinary teams in oncology, immunology, and biochemistry.